MedicarePartD.guide

A non-government resource built from CMS public data

VOYXACT 200 mg/mL Injection

Also known as Sibeprenlimab. Coverage in Alaska (CMS PDP Region 34).

Not on any stand-alone Part D formulary in Alaska

None of the 9 stand-alone Part D (PDP) plans in CMS PDP Region 34 list this drug. On one of those plans the patient would pay the full retail price, or you would need a formulary exception.

See coverage in all 39 regions →